172 related articles for article (PubMed ID: 38412029)
21. Altered expression of the L-arginine/nitric oxide pathway in ovarian cancer: metabolic biomarkers and biological implications.
Chen L; Tang Q; Zhang K; Huang Q; Ding Y; Jin B; Liu S; Hwa K; Chou CJ; Zhang Y; Thyparambil S; Liao W; Han Z; Mortensen R; Schilling J; Li Z; Heaton R; Tian L; Cohen HJ; Sylvester KG; Arent RC; Zhao X; McElhinney DB; Wu Y; Bai W; Ling XB
BMC Cancer; 2023 Sep; 23(1):844. PubMed ID: 37684587
[TBL] [Abstract][Full Text] [Related]
22. Untargeted UHPLC-ESI-QTOF-MS/MS analysis with targeted feature extraction at precursor and fragment level for profiling of the platelet lipidome with ex vivo thrombin-activation.
Cebo M; Calderón Castro C; Schlotterbeck J; Gawaz M; Chatterjee M; Lämmerhofer M
J Pharm Biomed Anal; 2021 Oct; 205():114301. PubMed ID: 34391135
[TBL] [Abstract][Full Text] [Related]
23. Validation of candidate serum ovarian cancer biomarkers for early detection.
Su F; Lang J; Kumar A; Ng C; Hsieh B; Suchard MA; Reddy ST; Farias-Eisner R
Biomark Insights; 2007 Oct; 2():369-75. PubMed ID: 19662218
[TBL] [Abstract][Full Text] [Related]
24. Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients.
Zhang L; Luo M; Yang H; Zhu S; Cheng X; Qing C
J Ovarian Res; 2019 Feb; 12(1):19. PubMed ID: 30786925
[TBL] [Abstract][Full Text] [Related]
25. Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer.
Ritter A; Hirschfeld M; Berner K; Jaeger M; Grundner-Culemann F; Schlosser P; Asberger J; Weiss D; Noethling C; Mayer S; Erbes T
Cancer Biomark; 2020; 27(2):225-242. PubMed ID: 32083575
[TBL] [Abstract][Full Text] [Related]
26. Complex metabolic interactions between ovary, plasma, urine, and hair in ovarian cancer.
Zhong X; Ran R; Gao S; Shi M; Shi X; Long F; Zhou Y; Yang Y; Tang X; Lin A; He W; Yu T; Han TL
Front Oncol; 2022; 12():916375. PubMed ID: 35982964
[TBL] [Abstract][Full Text] [Related]
27. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center.
Araujo KG; Jales RM; Pereira PN; Yoshida A; de Angelo Andrade L; Sarian LO; Derchain S
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):778-783. PubMed ID: 27194129
[TBL] [Abstract][Full Text] [Related]
28. Identification of Potential Biomarkers and Metabolic Profiling of Serum in Ovarian Cancer Patients Using UPLC/Q-TOF MS.
Yang W; Mu T; Jiang J; Sun Q; Hou X; Sun Y; Zhong L; Wang C; Sun C
Cell Physiol Biochem; 2018; 51(3):1134-1148. PubMed ID: 30476914
[TBL] [Abstract][Full Text] [Related]
29. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
Jiao J; Jiang L; Luo Y
Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
[TBL] [Abstract][Full Text] [Related]
30. Profiling the metabolome of uterine fluid for early detection of ovarian cancer.
Wang P; Ma J; Li W; Wang Q; Xiao Y; Jiang Y; Gu X; Wu Y; Dong S; Guo H; Li M
Cell Rep Med; 2023 Jun; 4(6):101061. PubMed ID: 37267943
[TBL] [Abstract][Full Text] [Related]
31. Machine Learning Developed a Programmed Cell Death Signature for Predicting Prognosis, Ecosystem, and Drug Sensitivity in Ovarian Cancer.
Wang L; Chen X; Song L; Zou H
Anal Cell Pathol (Amst); 2023; 2023():7365503. PubMed ID: 37868825
[TBL] [Abstract][Full Text] [Related]
32. Application of machine learning in prediction of Chemotherapy resistant of Ovarian Cancer based on Gut Microbiota.
Gong TT; He XH; Gao S; Wu QJ
J Cancer; 2021; 12(10):2877-2885. PubMed ID: 33854588
[No Abstract] [Full Text] [Related]
33. Lipidomic profiling reveals early-stage metabolic dysfunction in overweight or obese humans.
Mousa A; Naderpoor N; Mellett N; Wilson K; Plebanski M; Meikle PJ; de Courten B
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Mar; 1864(3):335-343. PubMed ID: 30586632
[TBL] [Abstract][Full Text] [Related]
34. Defining the lipid profiles of human milk, infant formula, and animal milk: implications for infant feeding.
George AD; Paul S; Wang T; Huynh K; Giles C; Mellett N; Duong T; Nguyen A; Geddes D; Mansell T; Saffery R; Vuillermin P; Ponsonby AL; Burgner D; Burugupalli S; Meikle PJ;
Front Nutr; 2023; 10():1227340. PubMed ID: 37712002
[TBL] [Abstract][Full Text] [Related]
35. Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer.
Zhao S; Zhang X; Gao F; Chi H; Zhang J; Xia Z; Cheng C; Liu J
Front Endocrinol (Lausanne); 2023; 14():1145797. PubMed ID: 36950684
[TBL] [Abstract][Full Text] [Related]
36. Ultrahigh resolution lipid mass spectrometry imaging of high-grade serous ovarian cancer mouse models.
Ma X; Botros A; Yun SR; Park EY; Kim O; Park S; Pham TH; Chen R; Palaniappan M; Matzuk MM; Kim J; Fernández FM
Front Chem; 2023; 11():1332816. PubMed ID: 38260043
[TBL] [Abstract][Full Text] [Related]
37. Large-scale lipidomics profiling reveals characteristic lipid signatures associated with an increased cardiovascular risk.
Harm T; Dittrich K; Brun A; Fu X; Frey M; Petersen Uribe A; Schwarz FJ; Rohlfing AK; Castor T; Geisler T; Rath D; Lämmerhofer M; Gawaz MP
Clin Res Cardiol; 2023 Nov; 112(11):1664-1678. PubMed ID: 37470807
[TBL] [Abstract][Full Text] [Related]
38. Five serum microRNAs for detection and predicting of ovarian cancer.
Wang W; Wu LR; Li C; Zhou X; Liu P; Jia X; Chen Y; Zhu W
Eur J Obstet Gynecol Reprod Biol X; 2019 Jul; 3():100017. PubMed ID: 31404211
[TBL] [Abstract][Full Text] [Related]
39. Ultrahigh Resolution Lipid Mass Spectrometry Imaging of High-Grade Serous Ovarian Cancer Mouse Models.
Ma X; Botros A; Yun SR; Park EY; Kim O; Chen R; Palaniappan M; Matzuk MM; Kim J; Fernández FM
bioRxiv; 2023 Nov; ():. PubMed ID: 37961688
[TBL] [Abstract][Full Text] [Related]
40. A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis.
FernÁndez-Eulate G; Ruiz-Sanz JI; Riancho J; ZufirÍa M; GereÑu G; FernÁndez-TorrÓn R; Poza-Aldea JJ; Ondaro J; Espinal JB; GonzÁlez-ChinchÓn G; Zulaica M; Ruiz-Larrea MB; LÓpez De Munain A; Gil-Bea FJ
Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):252-262. PubMed ID: 32106710
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
